Revenue change mental health market Germany

Over the forecast period until 2029, the revenue change is forecast to exhibit fluctuations among the three segments. Concerning the three selected segments, the segment Anxiety and Related Sleep Disorders has the largest revenue change with 0.61 percent. Contrastingly, Psychotic Disorders is ranked last, with 0.1 percent. Their difference, compared to Anxiety and Related Sleep Disorders, lies at 0.51 percentage points.

Revenue change in the mental health market in Germany from 2017 to 2029, by segment

Characteristic	Depressive Disorders	Psychotic Disorders	Anxiety and Related Sleep Disorders
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Mental health disorders are common illnesses found among people all over the world. These disorders are caused by a variety of genetic and environmental factors that cause imbalances in a person's physical and emotional behavior. Most mental health disorders can be treated with behavioral and psychotherapies. In some cases, however, medication is prescribed along with these treatments. The Mental Health market represents the market for the drugs that are used to treat various mild to serious mental health disorders. The market is divided into three markets that have been based on the disorders that are being treated. This includes depressive disorders, anxiety and related sleeping disorders, and different types of psychotic disorders.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, Johnson & Johnson, AbbVie, and Sumitomo pharma

Citation formats